Pure Global
NCT04869670

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

A Pilot and Feasibility Trial of G-POEM for Gastroparesis to Assess Safety, Physiological Mechanisms and Efficacy
Mayo Clinic·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Gastroparesis
Drug/Device/Intervention
Gastric peroral endoscopic myotomy.
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Scottsdale,Baltimore,Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 12, 2023
End date
Jul 01, 2025
Enrollment
30 participants
Primary outcome

GCSI-DD change

Summary

The purpose of this research is to evaluate the 12-month treatment effect of peroral
 endoscopic pyloromyotomy (G-POEM) vs. sham surgery in patients with gastroparesis that is not
 helped by medications and to analyze factors that may predict the outcome of the surgery.

ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04869670
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04869670 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Recruiting. The study focuses on Gastroparesis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.